CCRM Australia looks to the new decade with Australia as part of a worldwide regenerative medicine network without borders The coming decade is likely to bring significant advances
How CCRM Australia’s academic and industry partnerships helped an industry innovator connect with academic expertise and resources to deliver commercial-scale cell manufacturing. About Cynata Cynata is an Australian
The September 2019 issue of the CCRM Australia newsletter, #RegenMedAu, is now available to read. Here are some of the highlights for CCRM Australia in September: Sensors, the
Regenerative medicine is a risky business. The decades-long development pipeline and the expenditure of millions of dollars presents itself as an insurmountable mountain for many researchers. The regenerative
CCRM Australia has been helping early career researchers and high-achieving PhD candidates to gain the skills needed to commercialise and translate their regenerative medicine research into thriving business
The July 2019 issue of the CCRM Australia newsletter, #RegenMedAu, is now available to read. Here are some of the highlights for CCRM Australia in July: CCRM Au
Thanks to the inaugural CCRM Australia Global Network Exchange Program, Tel Aviv University PhD student Reut Guy has spent five weeks in Australia, building connections and furthering her
The Centre for Commercialization of Regenerative Medicine Australia and BioCurate enter into a Memorandum of Understanding (MoU) to accelerate the translation of therapies in the Australian regenerative medicine
Innovative and curative treatments push the limits of the government’s finite reimbursement purse. This pressing issue brings to light the growing concerns surrounding the reimbursement of cell therapies
The Centre for Commercialization of Regenerative Medicine Australia (CCRM Australia) is proud to partner with the MedTech Actuator to advance the translation and commercialisation of medical devices in
